Dabigatran versus warfarin in patients with atrial fibrillation by Connolly Stuart J, Ezekowitz Michael D, Yusuf Salim, Eikelboom John, Oldgren Jonas, Parekh Amit, Pogue Janice, Reilly Paul A, Themeles Ellison, Varrone Jeanne, Wang Susan, Alings Marco, Xavier Denis, Zhu Jun, Diaz Rafael, Lewis Basil S, Darius Harald, Diener Hans-Christoph, Joyner Campbell D, Wallentin Lars, RE-LY Steering Committee and Investigators in The New England journal of medicine (2009).

[PMID: 19717844] PubMed


Warfarin reduces the risk of stroke in patients with atrial fibrillation but increases the risk of hemorrhage and is difficult to use. Dabigatran is a new oral direct thrombin inhibitor.

[ hide abstract ]

Discussed In Paper


Related In Paper

Rx Annotations

No dosing information annotated.